Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zaltzman

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Transplantation Research|January 30, 2016
The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipientsAlina S R Zaltzman, Lauren A Glick, Jeffrey S Zaltzman, et al.
Boletin Medico Del Hospital Infantil De Mexico|October 1, 1991
[Nephropathy in Schönlein-Henoch purpura]O I Desinor-Mompoint, S García-De la Puente, B de León-Bojorge, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2002
Kidney transplantation in the elderly: a decision analysisSarbjit V Jassal, Murray D Krahn, Gary Naglie, et al.
Clinical Kidney Journal|February 2, 2013
A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome studyHelen Fanous, Rebecca Zheng, Carolyn Campbell, et al.
BMC Infectious Diseases|April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantationG V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Clinical Nephrology|February 11, 2009
Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantationG V Ramesh Prasad, M Huang, F Bandukwala, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 11, 2014
Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantationG V Ramesh Prasad, Michael Huang, Samuel A Silver, et al.
Transplantation|October 18, 2016
The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case StudyLucy Chen, Lisa Liberatore, Tom Chin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2010
South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantationG V Ramesh Prasad, Sai K Vangala, Samuel A Silver, et al.
Journal of Clinical Pharmacology|March 1, 1997
Pharmacokinetics of cyclosporine as a function of energy--protein deficiency in children with chronic renal failureI Lares-Asseff, S Zaltzman, M G Pérez Guillé, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Transplantation Research|January 30, 2016
The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipientsAlina S R Zaltzman, Lauren A Glick, Jeffrey S Zaltzman, et al.
Boletin Medico Del Hospital Infantil De Mexico|October 1, 1991
[Nephropathy in Schönlein-Henoch purpura]O I Desinor-Mompoint, S García-De la Puente, B de León-Bojorge, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2002
Kidney transplantation in the elderly: a decision analysisSarbjit V Jassal, Murray D Krahn, Gary Naglie, et al.
Clinical Kidney Journal|February 2, 2013
A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome studyHelen Fanous, Rebecca Zheng, Carolyn Campbell, et al.
BMC Infectious Diseases|April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantationG V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Clinical Nephrology|February 11, 2009
Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantationG V Ramesh Prasad, M Huang, F Bandukwala, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 11, 2014
Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantationG V Ramesh Prasad, Michael Huang, Samuel A Silver, et al.
Transplantation|October 18, 2016
The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case StudyLucy Chen, Lisa Liberatore, Tom Chin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2010
South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantationG V Ramesh Prasad, Sai K Vangala, Samuel A Silver, et al.
Journal of Clinical Pharmacology|March 1, 1997
Pharmacokinetics of cyclosporine as a function of energy--protein deficiency in children with chronic renal failureI Lares-Asseff, S Zaltzman, M G Pérez Guillé, et al.
Pageof 8